Hims & Hers Health Net Income 2020-2025 | HIMS
Hims & Hers Health annual/quarterly net income history and growth rate from 2020 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Hims & Hers Health net income for the quarter ending March 31, 2025 was $0.049B, a 344.69% increase year-over-year.
- Hims & Hers Health net income for the twelve months ending March 31, 2025 was $0.164B, a 7092.56% decline year-over-year.
- Hims & Hers Health annual net income for 2024 was $0.126B, a 635.28% decline from 2023.
- Hims & Hers Health annual net income for 2023 was $-0.024B, a 64.15% decline from 2022.
- Hims & Hers Health annual net income for 2022 was $-0.066B, a 38.99% decline from 2021.
| Hims & Hers Health Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $126 |
| 2023 | $-24 |
| 2022 | $-66 |
| 2021 | $-108 |
| 2020 | $-18 |
| 2019 | $-72 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $49 |
| 2024-12-31 | $26 |
| 2024-09-30 | $76 |
| 2024-06-30 | $13 |
| 2024-03-31 | $11 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-8 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-11 |
| 2022-09-30 | $-19 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-31 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-9 |
| 2021-03-31 | $-51 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-6 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $14.374B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |